DNA interaction, antimicrobial, antioxidant and anticancer studies on Cu(II) complexes of Luotonin A
Graphical Abstract
Introduction
The potent biological activities and clinical applications of pyrrologinazoline chromophore incorporated alkaloids had attracted intense attention worldwide and that have been isolated from natural sources [1]. A typical example is Luotonin A (L), pyrrolo–quinazolino–quinoline alkaloid originally isolated from a Chinese medicinal herb peganumnigellastrum that had been used to treat rheumatism, abscesses and inflammation [2], [3], [4]. It had been already reported that Luotonin A is a human DNA topoisomerase I inhibitor and exhibits potent cytotoxicity against murine leukemia P388 cell line by stabilizing the topoisomerase I/DNA complex with an IC50 value of 6.3 μM [5]. Luotonin A is structurally identical to another anticancer drug camptothecin which has strong topoisomerase I characteristics [6], [7]. There is a considerable interest in the study of biological properties of Luotonin A, because of its lower toxicity a higher chemical stability compared with campatothecin [8], [9], [10]. The biological activities such as anticancer, topoisomerase I inhibition) of natural products (Curcumin, Salinomycin, etc.) were enhanced by complex formation with metals. The discovery of anticancer drugs is one of the most rapidly developing areas in biological research [11] and it is essential to increase the variety of metal based natural products for achieving higher activity, enabling the administration of a lower dose, apoptosis on different types of tumor cells; it exhibits better selectivity and lower toxicity than cisplatin [12], [13], [14]. The Cu(II) adducts of 4-methoxypyrrolic marine natural products have also shown potent antitumor properties against breast, liver cancer cells by facilitating apoptosis [15], [16], [17], [18], [19], [20]. A Cu(II) complex prepared from Hypyramol shows interesting cytotoxic properties in selected cancer cell lines, comparable to the anticancer drug cisplatin [21]. Based on this view and our continuing interest [22], [23], [24], [25],the present report accounts for the preparation, characterization, DNA binding modes, antimicrobial screening studies and antitumor activities of Luotonin A centered on Cu(II) complexes 1 & 2 are described. Both complexes have potential screening effect against human breast cancer cell line (MCF-7) and cervical cancer cell line (HeLa) to understand their antitumor activity. The use of L in these complexes 1 & 2 is of considerable interest because several Cu(II) complexes of diimines strongly bind to DNA and exhibit potent anticancer activities by inducing cell death [26].
Section snippets
Materials and Instrumentation
Luotonin A (L) and copper(II) chloride by SIGMA, DMSO by MERCK are used for over all experiments as purchased. All other reagents and solvents are of analytical, spectroscopic grade and they are used without further purification. The Cu(II) complexes 1 & 2 are greenish yellow in color with DMSO.
Infrared spectra are recorded with KBr pellets using Perkin Elmer FT-IR 8000 spectrophotometer scans between 400 and 4000 cm1.Electronic spectra are recorded with a JASCO double beam UV–Vis
UV–Vis Spectral Analysis
The electronic spectra of L and its Cu(II) complexes 1 & 2 are recorded in DMSO at room temperature. The spectra of free ligand exhibit three absorption bands at 257, 344 and 362 nm as shown in Fig. S1. These bands are arises from π-π* and n-π* transition of the L. The electronic spectra of the complexes 1 & 2 in DMSO exhibit a intra ligand transition band at 254 nm and LMCT band at 327 nm, which confirms the complex formation of L with Cu(II) and evidently, the square planar stereochemistry
Electronic Absorption Spectra
The absorption spectral titration studies of complexes 1 & 2 with CT-DNA are shown in Fig. 2. Upon increasing the addition of DNA to Cu(II) complexes 1 & 2, the intensity changes occurred in intra ligand transition band at 254 nm and LMCT band at 324 nm. Hence, the DNA binding ability of complex 1 & 2 is studied by following the hypochromism of intra ligand transition band at 324 nm. For complex 1, the absorption bands of the ligand exhibits hypochromism with red shift of 5 nm. However, the
Antibacterial Screening
Antibacterial screening of the L and its Cu(II) complexes 1 & 2 (Fig. 6) have been carried out against the Escherichia coli, Staphylococcus aureus, Klebsiella pneumonia, Pseudomonas aeruginosa, Aeromonashydrphilia, Serratiamarcescenes and Proteus vulgari using Mueller-Hinton agar by well-diffusion method using DMSO as solvent [47], standard drug Amoxycillin. The comparative antimicrobial screening capability (in mm) of ligand L, complex 1, 2 and standard drug (Amoxycillin) are shown as in Fig. 6
DPPH Radical Scavenging Assay
A stock solution of DPPH prepared in DMSO to 3 × 10− 3 M. To explore the antioxidant activity of L, complex 1 & 2, free radical scavenging experiment carried out by the addition of different volumes of samples (40–160 μl) into 150 μl of stock solution of DPPH and is made up to 3 ml with DMSO. The reaction mixture is incubated in dark condition at room temperature for 20 min. After 20 min, the absorbance of the mixture is read at 520 nm. 3 ml of diluted DPPH is taken as control. The percentage of
MTT Cytotoxic Assay
The comparative cytotoxic activities of ligand L and its Cu(II) complexes 1 & 2 have been studied against human breast cancer cells MCsF-7 and HeLa cell lines by using MTT assay. The graphical representation of IC50 values for these compounds is given in Fig. 9. The IC50 values of L, complexes 1 & 2 against MCF-7 and HeLa cell lines with the incubation time intervals of 24 h are 1 (5.0 ± 0.25, 12.0 ± 0.30 μM) < 2 (6.5 ± 0.27, 15.0 ± 0.30 μM) < L (7.0 ± 0.15, 25.0 ± 0.35 μM) respectively. However, L and its Cu(II)
Conclusion
A new Cu(II) metal complexes 1 & 2 have been successfully prepared and characterized. The DNA binding mode of these complexes 1 & 2 with CT-DNA have been evaluated using absorption, emission spectral studies and viscosity measurements. A comparative antimicrobial screening and antitumor activities of prepared Cu(II) complexes 1 & 2 with ligand L have been studied. From absorption and emission spectral studies, complex 1 has higher DNA binding constant, Stern-Volmer constant and association
Acknowledgements
The authors gratefully acknowledge the DST-SERB (Ref. No: SB/FT/CS-130/2012) for financial assistance. The authors sincerely thank the management of Sethu Institute of Technology, Kariapatti and Mohamed Sathak Engineering College, Kilakarai for their lab and instrumental facilities.
References (49)
- et al.
The chemistry of recently isolated naturally occurring quinazolinone alkaloids
Tetrahedron
(2006) - et al.
Novel quinazoline - quinoline alkaloids with cytotoxic and DNA topoisomerase II inhibitory activities
Bioorg. Med. Chem. Lett.
(2004) - et al.
Synthesis and cytotoxic activity of substituted luotonin A derivatives
Bioorg. Med. Chem. Lett.
(2004) - et al.
Synthesis and topoisomerase poisoning activity of A-ring and E-ring substituted luotonin A derivatives
J. Inorg. Biochem.
(2007) - et al.
Synthesis and biochemical properties of E-ring modified luotonin a derivatives
Bioorg. Med. Chem. Lett.
(2004) - et al.
Efficient DNA cleavage mediated by mononuclear mixed ligand copper(II) phenolate complexes: the role of co-ligand planarity on DNA binding and cleavage and anticancer activity
J. Inorg. Biochem.
(2012) - et al.
Synthesis, characterization and binding studies of chromium(III) complex containing an intercalating ligand with DNA
J. Inorg. Biochem.
(2003) - et al.
Synthesis, spectra and DNA interactions of certain mononuclear transition metal (II) complexes of macrocyclic tetraazadiacetyl curcumin ligand
J. Mol. Struct.
(2012) - et al.
Analytical methods to determine the comparative DNA binding studies of curcumin–Cu (II) complexes
Spectrochim. Acta A Mol. Biomol. Spectrosc.
(2012) - et al.
Synthesis, characterization, DNA-binding and cleavage studies of polypyridyl copper (II) complexes
J. Mol. Struct.
(2014)
DNA binding and antibacterial studies of some polyethyleneimine-copper(II) complex samples containing 1,10 phenonthroline and l-theronine as coigands
Polyhedron
DNA binding and DNA cleavage studies of a water soluble cobalt(II) complex containing dinitrogen Schiff base ligand: the effect of metal on the mode of binding
Eur. J. Med. Chem.
Antimicrobial efficacy of phenanthrenequinone based Schiff base complexes incorporating methionine amino acid: structural elucidation and in vitro bio assay
Spectrochim. Acta A
Synthesis, spectroscopic,antimicrobial and DNA cleavage studies of new Co(II), Ni(II), Cu(II), Cd(II), Zn(II) and Hg(II) complexes with naphthofuran-2-carbohydrazide Schiff bases
J. Mol. Struct.
Mixed ligand copper(II) complexes of 1,10-phenanthroline with tridentate phenolate/pyridylbenz imidazolyl Schiff base ligands: covalent vs non-covalent DNA binding, DNA cleavage and cytotoxicity
J. Inorg. Biochem.
Synthesis and NA binding studies of Co(III) mixed-ligand complex containing dipyrido [3,2-a:2′,3′-c] phenazinesndphen
Polyhedron
Synthesis and crystal structure of a series of pyrazolone based Schiff base ligands and DNA binding studies of their copper complexes
J. Mol. Struct.
Synthesis, characterization, DNA interaction and in vitro cytotoxicity activities of ruthenium(II) Schiff base complexes
J. Mol. Struct.
Thermodynamic and structural study of phenanthroline derivative ruthenium complex/DNA interactions: probing partial intercalation and binding properties
J. Inorg. Biochem.
Metal based pharmacologically active complexes of Cu(II), Ni(II) and Zn(II): synthesis, spectral, XRD, antimicrobial screening, DNA interaction and cleavage investigation
J. Photochem. Photobiol. B
Synthesis and characterization of efficient chemical nucleases: a joint refinement from XRD, antimicrobial screening, DNA binding and cleavage investigations
Inorg. Chem. Commun.
A catalyst-free rapid, practical and general synthesis of 2-substituted quinazolin-4(3H)-ones leading to luotonin B and E, bouchardatine and 8-norrutaecarpine
RSC Adv.
One-pot synthesis of luotonin A and its analogues
Org. Lett.
Luotonin A. A naturally occurring human DNA topoisomerase I poison
J. Am. Chem. Soc.
Cited by (56)
Promising anticancer activity with high selectivity of DNA/plasma protein targeting new phthalazin-1(2H)-one heterocyclic scaffolds
2023, Journal of Molecular StructureAdvances in anticancer alkaloid-derived metallo-chemotherapeutic agents in the last decade: Mechanism of action and future prospects
2023, Pharmacology and TherapeuticsDesign, Synthesis, Bioanalytical, Photophysical and Chemo-phototherapeutic Studies of Heteroleptic Cu(II) Complexes
2022, Journal of the Taiwan Institute of Chemical EngineersDiscovery of metal-based complexes as promising antimicrobial agents
2021, European Journal of Medicinal Chemistry